PTPRZ1 and glioblastoma: To evaluate protein abundance, we analyzed n = 20 matched primary and recurrent glioblastoma samples and found patient-individual PTPRZ1 levels without temporal alterations between primary and recurrent tumors (Fig. 1e, f).